Abstract
Data from 59 patients with early rheumatoid arthritis were analysed to determine the predictive value of the possession of HLA-DR4 for disease severity and functional outcome at 3 years after disease onset. The previously reported association of that antigen with seropositive disease was confirmed. Conversely, however, there was no evidence that functional outcome was worse in the HLA-DR4 positive group as measured by the Stanford Health Assessment Questionnaire. The mean articular index was lower in the HLA-DR4 group which also had a smaller proportion with limited wrist extension. In addition, both patient and physicians' global assessment of disease status were better in the HLA-DR4 group. It is concluded that HLA-DR4 is not a useful predictor of poor outcome at 3 years.
Original language | English |
---|---|
Pages (from-to) | 233-235 |
Number of pages | 3 |
Journal | Rheumatology International |
Volume | 6 |
Issue number | 5 |
DOIs | |
Publication status | Published - Sep 1986 |
Keywords
- Disability
- Genetics
- HLA seropositivity
- Natural history
- Rheumatoid arthritis